You have read all your free articles, to continue reading subscribe to read the rest of this content.
Patent, pricing, production, and partnerships – these are the four Ps that companies must keep front and center for a successful market entry. Orexo’s CEO Nikolaj Sørensen answers some questions about how his company addressed these aspects when Orexo entered the US market. Although Orexo haAlready a subscriber Login You…
Ola Björkman from Let 'em know has provided us with his impressions from Arab Health 2017. Over 4,000 companies and 130,000 visitors from 160 countries gathered in Dubai this week – a crowded exhibition despite several halls with a total area equivalent to around ten football fields. At firAlready a…
Niels Abel Bonde, General Manager Novo Nordisk Sweden, will be elected new Chairman of the Board of Directors of Medicon Valley Alliance (MVA) at the upcoming 2023 Ordinary General Meeting. As the only candidate for the chairmanship and with unanimous support from the current board members represAlready a subscriber Login…
Danish biotech and drug companies are among the best in Europe when it comes to the number of candidate drugs under development, according to a new study. Nordic Life Sciences sector study 2014, by Ernst & Young, concludes that Denmark has the largest pipeline of drugs undergoing clinical trAlready a subscriber…
